The single-center, open-label, four-arm, exploratory study investigates the relation of different anti-diabetics to serum levels of active TGF-beta, a known pro-fibrotic stimulus, before and after a defined test meal.FindingsWe investigated sera of patients with type 2 diabetes mellitus…
Source: Anti-diabetic treatment regulates pro-fibrotic TGF-beta serum levels in type 2 diabetics
Saturday, August 31, 2013
Anti-diabetic treatment regulates pro-fibrotic TGF-beta serum levels in type 2 diabetics
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment